Data alert

Angiotensin-(1-7): New insights into the benefits of tissue ACE inhibition

Emerging new data are expanding our understanding of the renin-angiotensin system (RAS). In addition to angiotensin II (Ang II), at least 3 other peptides-Ang III, Ang IV, and Ang-(1-7)-have now been shown to possess biological activity and may have roles in regulation of blood pressure and endothelial function. The most important of these peptides is Ang-(1-7).


Download DA4.ppt (8 slides - 0.4MB)

Slide 1 Slide 2 Slide 3 Slide 4 Slide 5 Slide 6 Slide 7 Slide 8
Data_Alert.pdf (0.3MB)Data_Alert.pdf (0.3MB)


Related at vwbg.org

HOPE: New validation for the importance of tissue ACE inhibition

The results of the recently published HOPE (Heart Outcomes Prevention Evaluation) study provide powerful confirmation of the clinical benefits of tissue angiotensin-converting enzyme (ACE) inhibition, now strikingly demonstrated in patients at high risk for cardiovascular events.

Vascular Biology in Clinical Practice © Vol. 7, No. 1

ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection

This monograph, ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection , which is being offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Curriculum Update # 7

Managing renal disease for risk reduction: The expanding role of ACE inhibition

Chronic renal disease is a problem of increasing magnitude in the United States.
More related